Hidradenitis Suppurativa Remission and Progression in a Community Setting

Area of Science:

• Dermatology
• Chronic Inflammatory Diseases
• Epidemiology

Background:

• Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition with varying prevalence.
• Hospital-based studies suggest significant disease progression, but community-based data are lacking.
• Understanding HS disease course in the general population is crucial for accurate prognosis.

Purpose of the Study:

• To assess HS progression and remission rates in a community setting.
• To identify baseline factors predicting HS severity changes.
• To compare community-based HS disease course with hospital-based estimates.

Main Methods:

• Prospective cohort study with 10-year follow-up of a community-based HS cohort.
• Disease severity assessed using a modified Hurley score (mild, moderate, severe).
• Cox regression analysis explored baseline predictors of disease progression and remission.

Main Results:

• 107 patients with HS (53.3% mild, 18.7% moderate, 28.0% severe at baseline).
• 16.9% of non-severe HS progressed; 71.0% experienced remission (63.6% full remission).
• Remission rates varied by baseline severity (73.7% mild, 60.0% moderate, 46.7% severe).
• No baseline demographic factors predicted disease development.

Conclusions:

• Community-based HS progression is significantly lower (10.4x) than hospital-based estimates.
• Community-based HS remission rates are significantly higher (3.8x) than hospital-based estimates.
• HS may have a more favorable disease course in the general population than previously thought.